NCT07383493

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: University Hospital, Clermont-Ferrand · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to conduct post-marketing clinical follow-up of four products: NS, NHE, NHG, and PIR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of acute viral rhinitis, rhinosinusitis, and rhinopharyngitis, while also assessing the benefit/risk ratio of the products.

Conditions

• Rhinitis Acute
• Rhinitis Viral
• Rhinosinusitis Acute
• Rhinopharyngitis
• Rhinitis
• Rhinosinusitis

Interventions

Type	Name	Description
DEVICE	PIR	Patients included in the "PIR" arm will receive the medical device of the same name.
DEVICE	NS	Patients included in the "NS" arm will receive the medical device of the same name.
DEVICE	NHE	Patients included in the "NHE" arm will receive the medical device of the same name.
DEVICE	NHG	Patients included in the "NHG" arm will receive the medical device of the same name.

Timeline

• Start date: 2026-02-01
• Primary completion: 2027-03-01
• Completion: 2027-03-01
• First posted: 2026-02-03
• Last updated: 2026-02-03

Locations

1 site across 1 country: France